UBS Group
PASG icon

UBS Group’s Passage Bio PASG Stock Holding History

UBS Group’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$66.2K Sell
13,565
-13,936
-51% -$87.2K ﹤0.01% 7422
2026
Q1 		$216K Buy
27,501
+26,059
+1,807% +$270K ﹤0.01% 6596
2025
Q4 		$17K Buy
1,442
+1,425
+8,382% +$12.3K ﹤0.01% 7899
2025
Q3 		$137 Buy
+17
New +$118 ﹤0.01% 9874
2025
Q2 		– Sell
-724
Closed -$5.29K – 10194
2025
Q1 		$5.11K Buy
+724
New +$7.83K ﹤0.01% 9031
2024
Q4 		– Hold
0
– – – 9861
2024
Q3 		– Sell
-57
Closed -$910 – 9918
2024
Q2 		$910 Buy
+57
New +$1.4K ﹤0.01% 8739
2024
Q1 		– Sell
-53
Closed -$1.07K – 9838
2023
Q4 		$1.07K Buy
+53
New +$732 ﹤0.01% 8413
2023
Q1 		– Sell
-88
Closed -$2.43K – 10163
2022
Q4 		$2.43K Sell
88
-504
-85% -$12.7K ﹤0.01% 9682
2022
Q3 		$15K Buy
+592
New +$23.3K ﹤0.01% 7819
2022
Q2 		– Sell
-69
Closed -$4K – 10752
2022
Q1 		$4K Sell
69
-987
-93% -$81.3K ﹤0.01% 9308
2021
Q4 		$134K Buy
1,056
+1,002
+1,856% +$164K ﹤0.01% 6028
2021
Q3 		$11K Sell
54
-331
-86% -$78.9K ﹤0.01% 7898
2021
Q2 		$102K Sell
385
-1,688
-81% -$522K ﹤0.01% 5861
2021
Q1 		$725K Buy
2,073
+1,977
+2,059% +$844K ﹤0.01% 4560
2020
Q4 		$49K Buy
+96
New +$38.4K ﹤0.01% 6204
2020
Q3 		– Sell
-231
Closed -$126K – 8301
2020
Q2 		$126K Buy
+231
New +$104K ﹤0.01% 5124

Other funds holding PASG

LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $291M AUM 19.43% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VA
Verdad Advisers Boston, Massachusetts $104M AUM
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

UBS Group's PASG Position: Q2 2026 in Review

UBS Group reduced its Passage Bio (PASG) stake by 51% in Q2 2026, selling an estimated $87.2K and leaving 13,565 shares worth $66.2K. The position accounts for ﹤0.01% of the portfolio, ranked #7422.

UBS Group first reported a position in PASG in Q2 2020 and has held it in 16 quarters since. The position peaked at $725K in Q1 2021. 29 funds tracked by Wall St. Rank hold PASG as of Q2 2026.

  • UBS Group held 13,565 shares of Passage Bio worth $66.2K as of Q2 2026.
  • UBS Group sold 13,936 Passage Bio shares in Q2 2026, an estimated $87.2K.
  • Passage Bio made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #7422 holding.
  • UBS Group first reported a position in Passage Bio in Q2 2020 and has held it in 16 quarters since.
  • UBS Group's Passage Bio position peaked at $725K in Q1 2021.
  • 29 funds tracked by Wall St. Rank held Passage Bio as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.